Ambient air pollution in relation to SARS-CoV-2 infection, antibody response, and COVID-19 disease: a Cohort study in Catalonia, Spain (COVICAT Study)

Kogevinas, Manolis; Castaño Vinyals, Gemma; Karachaliou, Marianna; Espinosa, Ana; García Aymerich, Judith; Jiménez, Alfons; Vidal, Marta; O’Callaghan-Gordo, Cristina; Cirach, Marta; Santano, Rebeca; Barrios, Diana; Puyol, Laura; Rubio, Rocío; Izquierdo, Luis; Nieuwenhuijsen, Mark J.; Dadvand, Payam; Aguilar, Ruth; Moncunill, Gemma; Dobaño, Carlota; Tonne, Cathryn

doi:http://dx.doi.org/10.1289/EHP9726

Ambient air pollution in relation to SARS-CoV-2 infection, antibody response, and COVID-19 disease: a Cohort study in Catalonia, Spain (COVICAT Study)

Citation

Kogevinas M, Castaño-Vinyals G, Karachaliou M, Espinosa A, de Cid R, Garcia-Aymerich J, et al. Ambient air pollution in relation to SARS-CoV-2 infection, antibody response, and COVID-19 disease: a Cohort study in Catalonia, Spain (COVICAT Study). Environ Health Perspect. 2021 Nov; 129(11): 117003. DOI: 10.1289/EHP9726

Abstract

Background: emerging evidence links ambient air pollution with coronavirus 2019 (COVID-19) disease, an association that is methodologically challenging to investigate. Objectives: we examined the association between long-term exposure to air pollution with SARS-CoV-2 infection measured through antibody response, level of antibody response among those infected, and COVID-19 disease. Methods: we contacted 9,605 adult participants from a population-based cohort study in Catalonia between June and November 2020; most participants were between 40 and 65 years of age. We drew blood samples from 4,103 participants and measured immunoglobulin M (IgM), IgA, and IgG antibodies against five viral target antigens to establish infection to the virus and levels of antibody response among those infected. We defined COVID-19 disease using self-reported hospital admission, prior positive diagnostic test, or more than three self-reported COVID-19 symptoms after contact with a COVID-19 case. We estimated prepandemic (2018-2019) exposure to fine particulate matter [PM with an aerodynamic diameter of ≤2.5μ m ( PM 2.5 )], nitrogen dioxide ( NO2 ), black carbon (BC), and ozone ( O3 ) at the residential address using hybrid land-use regression models. We calculated log-binomial risk ratios (RRs), adjusting for individual- and area-level covariates. Results: among those tested for SARS-CoV-2 antibodies, 743 (18.1%) were seropositive. Air pollution levels were not statistically significantly associated with SARS-CoV-2 infection: Adjusted RRs per interquartile range were 1.07 (95% CI: 0.97, 1.18) for NO 2, 1.04 (95% CI: 0.94, 1.14) for PM 2.5 , 1.00 (95% CI: 0.92, 1.09) for BC, and 0.97 (95% CI: 0.89, 1.06) for O3. Among infected participants, exposure to NO2 and PM 2.5 were positively associated with IgG levels for all viral target antigens. Among all participants, 481 (5.0%) had COVID-19 disease. Air pollution levels were associated with COVID-19 disease: adjusted RRs = 1.14 (95% CI: 1.00, 1.29) for NO2 and 1.17 (95% CI: 1.03, 1.32) for PM 2.5. Exposure to O3 was associated with a slightly decreased risk (RR = 0.92; 95% CI: 0.83, 1.03). Associations of air pollution with COVID-19 disease were more pronounced for severe COVID-19, with RRs = 1.26 (95% CI: 0.89, 1.79) for NO 2 and 1.51 (95% CI: 1.06, 2.16) for PM 2.5. Discussion: exposure to air pollution was associated with a higher risk of COVID-19 disease and level of antibody response among infected but not with SARS-CoV-2 infection. https://doi.org/10.1289/EHP9726.